These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 1530970)

  • 1. Myocardial extraction of teboroxime: effects of teboroxime interaction with blood.
    Rumsey WL; Rosenspire KC; Nunn AD
    J Nucl Med; 1992 Jan; 33(1):94-101. PubMed ID: 1530970
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Measurement of myocardial blood flow using a co-injection technique for technetium-99m-teboroxime, technetium-96-sestamibi and thallium-201.
    Di Rocco RJ; Rumsey WL; Kuczynski BL; Linder KE; Pirro JP; Narra RK; Nunn AD
    J Nucl Med; 1992 Jun; 33(6):1152-9. PubMed ID: 1534576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advances in myocardial perfusion imaging: 99mTc-teboroxime.
    Pieri PL; Strauss HW
    J Nucl Biol Med (1991); 1992; 36(2 Suppl):22-8. PubMed ID: 1450239
    [No Abstract]   [Full Text] [Related]  

  • 4. The new 99mTc myocardial perfusion imaging agents: 99mTc-sestamibi and 99mTc-teboroxime.
    Berman DS; Kiat H; Maddahi J
    Circulation; 1991 Sep; 84(3 Suppl):I7-21. PubMed ID: 1832100
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Uptake kinetics of technetium-99m-methoxyisobutylisonitrile and thallium-201 in adult rat heart endothelial and fibroblast-like cells in comparison to myocytes.
    Caldwell JH; Mertens H; Linssen MC; van der Vusse GJ; Buell U; Kammermeier H
    J Nucl Med; 1992 Jan; 33(1):102-7. PubMed ID: 1530964
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extraction and retention of technetium-99m Q12, technetium-99m sestamibi, and thallium-201 in isolated rat heart during coronary acidemia.
    McGoron AJ; Gerson MC; Biniakiewicz DS; Roszell NJ; Washburn LC; Millard RW
    Eur J Nucl Med; 1997 Dec; 24(12):1479-86. PubMed ID: 9391182
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Physiological basis of myocardial perfusion imaging with the technetium 99m agents.
    Beller GA; Watson DD
    Semin Nucl Med; 1991 Jul; 21(3):173-81. PubMed ID: 1835136
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Uptake of technetium-99m-teboroxime in cultured myocardial cells: comparison with thallium-201 and technetium-99m-sestamibi.
    Maublant JC; Moins N; Gachon P; Renoux M; Zhang Z; Veyre A
    J Nucl Med; 1993 Feb; 34(2):255-9. PubMed ID: 8429344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Teboroxime, sestamibi and thallium-201 as markers of myocardial hypoperfusion: comparison by quantitative dual-isotope autoradiography in rabbits.
    Weinstein H; Reinhardt CP; Leppo JA
    J Nucl Med; 1993 Sep; 34(9):1510-7. PubMed ID: 8355072
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro uptake of technetium-99m-teboroxime in carcinoma cell lines and normal cells: comparison with technetium-99m-sestamibi and thallium-201.
    Maublant JC; Zhang Z; Rapp M; Ollier M; Michelot J; Veyre A
    J Nucl Med; 1993 Nov; 34(11):1949-52. PubMed ID: 8229240
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between in vitro transendothelial permeability and in vivo single-pass brain extraction.
    Pirro JP; Di Rocco RJ; Narra RK; Nunn AD
    J Nucl Med; 1994 Sep; 35(9):1514-9. PubMed ID: 8071703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Physiologic properties of myocardial perfusion tracers.
    Dahlberg ST; Leppo JA
    Cardiol Clin; 1994 May; 12(2):169-85. PubMed ID: 8033171
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Experimental studies of the physiologic properties of technetium-99m agents: myocardial transport of perfusion imaging agents.
    Meerdink DJ; Leppo JA
    Am J Cardiol; 1990 Oct; 66(13):9E-15E. PubMed ID: 2145753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kinetic analysis of 125I-iodorotenone as a deposited myocardial flow tracer: comparison with 99mTc-sestamibi.
    Marshall RC; Powers-Risius P; Reutter BW; Taylor SE; VanBrocklin HF; Huesman RH; Budinger TF
    J Nucl Med; 2001 Feb; 42(2):272-81. PubMed ID: 11216526
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of triphenyl tetrazolium chloride staining on the distribution of radiolabeled pharmaceuticals.
    Reinhardt CP; Weinstein H; Wironen J; Leppo JA
    J Nucl Med; 1993 Oct; 34(10):1722-7. PubMed ID: 7692020
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myocardial technetium-99m-teboroxime uptake during adenosine-induced hyperemia in dogs with either a critical or mild coronary stenosis: comparison to thallium-201 and regional blood flow.
    Glover DK; Ruiz M; Bergmann EE; Simanis JP; Smith WH; Watson DD; Beller GA
    J Nucl Med; 1995 Mar; 36(3):476-83. PubMed ID: 7884514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of flow on technetium-99m-teboroxime (SQ30217) and thallium-201 extraction and retention in rabbit heart.
    Marshall RC; Leidholdt EM; Zhang DY; Barnett CA
    J Nucl Med; 1991 Oct; 32(10):1979-88. PubMed ID: 1919742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Planar myocardial perfusion imaging with technetium-99m-teboroxime: comparison by vascular territory with thallium-201 and coronary angiography.
    Dahlberg ST; Weinstein H; Hendel RC; McSherry B; Leppo JA
    J Nucl Med; 1992 Oct; 33(10):1783-8. PubMed ID: 1403145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myocardial kinetics of technetium-99m teboroxime in the presence of postischemic injury, necrosis and low flow reperfusion.
    Beanlands RS; DeKemp RA; Harmsen E; Veinot JP; Hartman NG; Ruddy TD
    J Am Coll Cardiol; 1996 Aug; 28(2):487-94. PubMed ID: 8800130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kinetics of technetium-99m-teboroxime in reperfused nonviable myocardium.
    Okada RD; Glover DK; Moffett JD; Beju D; Johnson G
    J Nucl Med; 1997 Feb; 38(2):274-9. PubMed ID: 9025755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.